Quantitative imaging of disease signatures through radioactive decay signal conversion

Nature Medicine

Volumn 19, Issue 10, 2013, Pages 1345-1350

  Thorek, Daniel L J ^a   Ogirala, Anuja ^a   Beattie, Bradley J ^a   Grimm, Jan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GELATINASE A; NANOPARTICLE; QUANTUM DOT; RADIOISOTOPE;

ARTICLE; CERENKOV LUMINESCENCE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DISEASE MARKER; ELECTRON; ENZYME ACTIVITY; FEMALE; FLUORESCENCE IMAGING; IN VITRO STUDY; IN VIVO STUDY; LUMINESCENCE; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DECAY; ZYMOGRAPHY; ANIMAL; CLASSIFICATION; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; DISEASES; FLUORESCENCE; METABOLISM; PROCEDURES;

ANIMALS; DIAGNOSTIC IMAGING; DISEASE; FLUORESCENCE; MATRIX METALLOPROTEINASE 2; MICE; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES;

EID: 84887479739     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3323     Document Type: Article

References (35)

1. Miyagawa, T. et al. Imaging of HSV-tk Reporter gene expression: Comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes. J. Nucl. Med. 49, 637-648 (2008)
2. Tjuvajev, J.G. et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J. Nucl. Med. 43, 1072-1083 (2002)
3. Thorek, D.L. & Grimm, J. Enzymatically activatable diagnostic probes. Curr. Pharm. Biotechnol. 13, 523-536 (2012)
4. Grimm, J. et al. Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc. Natl. Acad. Sci. USA 102, 14404-14409 (2005)
5. Weissleder, R., Tung, C.H., Mahmood, U. & Bogdanov, A. Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-378 (1999)
6. Rudin, M. & Weissleder, R. Molecular imaging in drug discovery and development. Nat. Rev. Drug Discov. 2, 123-131 (2003).
7. Chuang, C.H. et al. In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrate. Clin. Cancer Res. 18, 238-247 (2012)
8. L'Annunziata, M.F. Radioactivity: Introduction and History 429 (Elsevier, Oxford, 2007)
9. Robertson, R. et al. Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys. Med. Biol. 54, N355-N365 (2009)
10. Ruggiero, A., Holland, J.P., Lewis, J.S. & Grimm, J. Cerenkov luminescence imaging of medical isotopes. J. Nucl. Med. 51, 1123-1130 (2010)
11. Liu, H. et al. Molecular optical imaging with radioactive probes. PLoS ONE 5, e9470 (2010)
12. Dothager, R.S., Goiffon, R.J., Jackson, E., Harpstrite, S. & Piwnica-Worms, D. Cerenkov radiation energy transfer (CRET) imaging: a novel method for optical imaging of PET isotopes in biological systems. PLoS ONE 5, e13300 (2010)
13. Liu, H. et al. Radiation-luminescence-excited quantum dots for in vivo multiplexed optical imaging. Small 6, 1087-1091 (2010)
14. Jelley, J.V. Cerenkov radiation and its applications. Br. J. Appl. Phys. 6, 227 (1955)
15. Dijkers, E.C. et al. Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin. Pharmacol. Ther. 87, 586-592 (2010)
16. Turk, B.E., Huang, L.L., Piro, E.T. & Cantley, L.C. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat. Biotechnol. 19, 661-667 (2001)
17. Väisänen, A., Kallioinen, M., Taskinen, P.J. & Turpeenniemi-Hujanen, T. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. J. Pathol. 186, 51-58 (1998)
18. Davidson, B. et al. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma-a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol. Oncol. 73, 372-382 (1999)
19. Määttä, M., Soini, Y., Liakka, A. & Autio-Harmainen, H. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin. Cancer Res. 6, 2726-2734 (2000)
20. Dubertret, B., Calame, M. & Libchaber, A.J. Single-mismatch detection using gold-quenched fluorescent oligonucleotides. Nat. Biotechnol. 19, 365-370 (2001)
21. Lee, S. et al. A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination. Angew. Chem. Int. Ed. Engl. 47, 2804-2807 (2008)
22. Frank, I. & Tamm, I. Coherent visible radiation of fast electrons passing through matter. Compt. Rend. Dokl. Akad. Mauk. SSSR. 14, 109-114 (1937)
23. Xu, Y., Piston, D.W. & Johnson, C.H. A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc. Natl. Acad. Sci. USA 96, 151-156 (1999)
24. So, M.K., Xu, C., Loening, A.M., Gambhir, S.S. & Rao, J. Self-illuminating quantum dot conjugates for in vivo imaging. Nat. Biotechnol. 24, 339-343 (2006)
25. Quon, A. & Gambhir, S.S. FDG-PET and beyond: molecular breast cancer imaging. J. Clin. Oncol. 23, 1664-1673 (2005)
26. Beattie, B.J. et al. Quantitative modeling of Cerenkov light production efficiency from medical radionuclides. PLoS ONE 7, e31402 (2012)
27. Kothapalli, S.R., Liu, H., Liao, J.C., Cheng, Z. & Gambhir, S.S. Endoscopic imaging of Cerenkov luminescence. Biomed. Opt. Express 3, 1215-1225 (2012)
28. Holland, J.P., Normand, G., Ruggiero, A., Lewis, J.S. & Grimm, J. Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions. Mol. Imaging 10, 177-186 (2011)
29. Holland, J.P., Sheh, Y. & Lewis, J.S. Standardized methods for the production of high specific-activity zirconium-89. Nucl. Med. Biol. 36, 729-739 (2009)
30. Holland, J.P. et al. Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab. PLoS ONE 5, e8859 (2010)
31. Cai, W. & Chen, X. Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging. Nat. Protoc. 3, 89-96 (2008)
32. Institute of Laboratory Animal Resources (U.S.)
33. Committee on Care and Use of Laboratory Animals. Guide for the care and use of laboratory animals. in NIH publication v. (U.S. Department of Health and Human Services, Public Health Service, Bethesda, MD)
34. Flock, S.T., Jacques, S.L., Wilson, B.C., Star, W.M. & van Gemert, M.J. Optical properties of Intralipid: a phantom medium for light propagation studies. Lasers Surg. Med. 12, 510-519 (1992)
35. Rosenblum, G. et al. Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2), J. Biol. Chem. 278 27009-27015, (2003).